SIGA insider trading
NasdaqGM HealthcareSIGA TECHNOLOGIES INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About SIGA TECHNOLOGIES INC
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Company website: www.siga.com
SIGA insider activity at a glance
FilingIQ has scored 294 insider transactions for SIGA since Sep 17, 2013. The most recent filing in our index is dated Mar 25, 2026.
Across the full history, 11 open-market purchases
and 9 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on SIGA insider trades is 58.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for SIGA?
- FilingIQ tracks 294 Form 4 insider transactions for SIGA (SIGA TECHNOLOGIES INC), covering filings from Sep 17, 2013 onwards. 19 of those were filed in the last 90 days.
- Are SIGA insiders net buyers or net sellers?
- Across the full Form 4 history for SIGA, 11 transactions (4%) were open-market purchases and 9 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does SIGA insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is SIGA in?
- SIGA TECHNOLOGIES INC (SIGA) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $489.46M.
Methodology & sources
Every SIGA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.